Paul Williams
Equibles does not estimate personal net worth.
About Paul Williams
Emergent BioSolutions Inc. reported in an 8-K filed January 9, 2023 that Paul Williams was appointed Senior Vice President Products Business. The proxy statement of Emergent BioSolutions Inc. reports total compensation of $1,391,158 for Paul Williams in fiscal 2025, including a base salary of $495,019. Disclosed compensation is on record for 3 fiscal years. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
“The Company also announced the appointment of Paul Williams as the Company's Senior Vice President Products Business, reporting to the Company's CEO, Robert Kramer.”
Affiliation history
-
Emergent BioSolutions Inc. (EBS)
Proxy statement
CurrentStart not stated–present
Last confirmed March 20, 2026
Company network
Leadership on record at Emergent BioSolutions Inc.
- Daniel J. Abdun-Nabi CEO, COO, Board Member
- Joseph C. Papa CEO, Board Member
- Joseph Papa CEO, Board Member
- Robert G. Kramer, Sr. CEO, Board Member
- Zsolt Harsanyi Chairman, Board Member
- Frank Vargo CFO
- Richard S. Lindahl CFO
- Robert G. Kramer CFO
- Adam Havey COO
- Jessica Perl General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Emergent BioSolutions Inc. (EBS) | Senior Vice President, Products Business | $495,019 | $1,391,158 |
| 2024 | Emergent BioSolutions Inc. (EBS) | Senior Vice President, Products Business | $469,560 | $1,675,687 |
| 2023 | Emergent BioSolutions Inc. (EBS) | Senior Vice President, Products Business | $445,775 | $1,063,639 |